BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7759243)

  • 1. [Pseudoglucagonoma syndrome. Case report, therapeutic possibilities and hypotheses on the etiology].
    Ossowski B; Baum C
    Hautarzt; 1995 Mar; 46(3):173-6. PubMed ID: 7759243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Erythema necroticans migrans without glucagonoma].
    Tanner M; Brasch J; Christophers E
    Hautarzt; 1994 Jul; 45(7):480-3. PubMed ID: 7928344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Erythema necroticans migrans in non-glucagon-secreting pancreas tumor].
    Wilde O; Peters B; Doll T; Füchtenbusch M
    Hautarzt; 2007 Dec; 58(12):1014-6. PubMed ID: 17994204
    [No Abstract]   [Full Text] [Related]  

  • 4. A serpiginous eruption.
    Esdaile BA; Hollowood K; Burge S
    Arch Dermatol; 2012 Mar; 148(3):385-90. PubMed ID: 22431782
    [No Abstract]   [Full Text] [Related]  

  • 5. Necrolytic migratory erythema: the outermost marker for glucagonoma syndrome.
    Gantcheva ML; Broshtilova VK; Lalova AI
    Arch Dermatol; 2007 Sep; 143(9):1221-2. PubMed ID: 17875900
    [No Abstract]   [Full Text] [Related]  

  • 6. [The glucagonoma syndrome].
    Rappersberger K; Wolff-Schreiner E; Konrad K; Wolff K
    Hautarzt; 1987 Oct; 38(10):589-98. PubMed ID: 2824404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Migratory necrolytic erythema and glucagonoma.
    Echenique-Elizondo M; Elorza JL; De Delas JS
    Surgery; 2003 Apr; 133(4):449-50. PubMed ID: 12717367
    [No Abstract]   [Full Text] [Related]  

  • 8. Octreotide-responsive necrolytic migratory erythema in a patient with pseudoglucagonoma syndrome.
    Virani S; Prajapati V; Devani A; Mahmood MN; Elliott JF
    J Am Acad Dermatol; 2013 Feb; 68(2):e44-6. PubMed ID: 23317985
    [No Abstract]   [Full Text] [Related]  

  • 9. Iatrogenic necrolytic migratory erythema: a case report and review of nonglucagonoma-associated necrolytic migratory erythema.
    Mullans EA; Cohen PR
    J Am Acad Dermatol; 1998 May; 38(5 Pt 2):866-73. PubMed ID: 9591806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Necrolytic migratory erythema and pancreatic glucagonoma.
    Rodríguez G; Vargas E; Abaúnza C; Cáceres S
    Biomedica; 2016 Jun; 36(2):176-81. PubMed ID: 27622478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A patient with long-standing skin lesions. Necrolytic migratory erythema.
    Netea RT; Erceg A; Pieters G; Hermus AR
    Neth J Med; 2004 Dec; 62(11):453, 462. PubMed ID: 15685896
    [No Abstract]   [Full Text] [Related]  

  • 12. Glucagonoma syndrome with atypical necrolytic migratory erythema.
    He S; Zeng W; Geng S; Jia J
    Indian J Dermatol Venereol Leprol; 2021; 87(1):49-53. PubMed ID: 31368453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Necrolytic migratory erythema.
    Kovács RK; Korom I; Dobozy A; Farkas G; Ormos J; Kemény L
    J Cutan Pathol; 2006 Mar; 33(3):242-5. PubMed ID: 16466513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagonoma syndrome: case report and literature review.
    Parker CM; Hanke CW; Madura JA; Liss EC
    J Dermatol Surg Oncol; 1984 Nov; 10(11):884-9. PubMed ID: 6092443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Necrolytic migratory erythema. A marker of systemic disease].
    de Cristancho NP; Rivera J; de Arriaga AD
    Rev Clin Esp; 1994 Aug; 194(8):654. PubMed ID: 7938851
    [No Abstract]   [Full Text] [Related]  

  • 16. What is your diagnosis? Necrolytic migratory erythema associated with a glucagonoma.
    Chaw L; Krop TM; Hood AF
    Cutis; 2008 Jan; 81(1):25, 30-2. PubMed ID: 18306843
    [No Abstract]   [Full Text] [Related]  

  • 17. [Necrolytic migratory erythema in glucagonoma syndrome].
    Stark I; Mensing CH; Sander CA
    Hautarzt; 2008 Jan; 59(1):50-3. PubMed ID: 17549440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The question of surgical therapy for necrolytic migratory erythema, a cutaneous disease].
    Siegel R; Linse R; Rau B
    Chirurg; 2006 Jun; 77(6):535-8. PubMed ID: 16362349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Necrolytic Migratory Erythema: A Forgotten Paraneoplastic Condition.
    Tremblay C; Marcil I
    J Cutan Med Surg; 2017; 21(6):559-561. PubMed ID: 28662584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Necrolytic migratory erythema, first symptom of a malignant glucagonoma: treatment by long-acting somatostatin and surgical resection. Report of three cases.
    El Rassi Z; Partensky C; Valette PJ; Berger F; Chayvialle JA
    Eur J Surg Oncol; 1998 Dec; 24(6):562-7. PubMed ID: 9870735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.